Understanding how skin lymphomas develop from specific immune cells
Mechanisms of Lymphomagenesis of Skin Resident Gamma Delta T cells
This study is looking into a type of aggressive skin cancer called primary cutaneous gamma delta T cell lymphoma, aiming to understand how it develops so that researchers can find new ways to treat it and improve survival for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11001551 on NIH RePORTER |
What this research studies
This research investigates primary cutaneous gamma delta T cell lymphomas, which are aggressive skin cancers that arise from a specific type of immune cell. The study aims to uncover the underlying mechanisms of this disease by analyzing a large collection of patient samples to identify genetic and cellular factors involved in its development. By utilizing advanced genomic and immunological techniques, the researchers hope to discover new therapeutic targets that could lead to better treatment options for patients. This work is crucial as current survival rates for this type of lymphoma are low, and understanding its biology may pave the way for innovative therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with primary cutaneous gamma delta T cell lymphomas or those with related skin lymphomas.
Not a fit: Patients with other types of lymphomas or skin cancers that do not involve gamma delta T cells may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments that significantly improve survival rates for patients with aggressive skin lymphomas.
How similar studies have performed: While research on gamma delta T cells is ongoing, this specific investigation into their role in skin lymphomas is relatively novel and has not been extensively tested.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Le Poole, I. Caroline — Northwestern University at Chicago
- Study coordinator: Le Poole, I. Caroline
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.